Skip to main content
Man Who Predicted March 2020 Crash Says 2021 Is The Time
If you've got money invested in the stock market, but are confused as to what to do next...This is the can't-miss interview of 2021...

NYSE:CYH - Community Health Systems Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $10.88
  • Forecasted Upside: -28.55 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$15.22
▲ +1.21 (8.64%)
1 month | 3 months | 12 months
Get New Community Health Systems Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CYH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CYH

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$10.88
▼ -28.55% Downside Potential
This price target is based on 4 analysts offering 12 month price targets for Community Health Systems in the last 3 months. The average price target is $10.88, with a high forecast of $18.00 and a low forecast of $3.50. The average price target represents a -28.55% upside from the last price of $15.22.
Legendary Crypto Analyst Names 3 Coins to Buy Instead of Coinbase
Matt McCall’s crypto portfolio has delivered multiple 1,000% winners in just months…

Now he’s naming 3 tokens he believes folks should own instead of the Coinbase stock in a free report.
pixel

Hold

The current consensus among 4 contributing investment analysts is to hold stock in Community Health Systems. This rating has held steady since February 2020, when it changed from a Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 4 sell ratings
11/14/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 3 sell ratings
2/12/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
5/12/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
8/10/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
11/8/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
2/6/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/7/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/7/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/6/2021Credit Suisse GroupUpgradeUnderperform ➝ Neutral$4.10 ➝ $10.00Low
i
5/5/2021Jefferies Financial GroupUpgradeHold ➝ Buy$11.00 ➝ $18.00High
i
4/30/2021Credit Suisse GroupUpgradeUnderperform ➝ Neutral$4.10 ➝ $10.00High
i
4/14/2021TruistBoost Price Target$9.00 ➝ $12.00Low
i
2/25/2021Credit Suisse GroupBoost Price TargetUnderperform$3.50 ➝ $4.10Medium
i
1/5/2021TruistBoost Price Target$7.00 ➝ $8.00N/A
i
8/6/2020Raymond JamesReiterated RatingHoldLow
i
6/11/2020CitigroupBoost Price TargetNeutral$3.00 ➝ $3.50Medium
i
5/4/2020OppenheimerLower Price TargetOutperform$8.00 ➝ $7.00High
i
4/28/2020OppenheimerReiterated RatingBuy$8.00High
i
2/24/2020Royal Bank of CanadaReiterated RatingSector Perform$8.00Low
i
2/20/2020Raymond JamesUpgradeUnderperform ➝ Market PerformHigh
i
12/18/2019SunTrust BanksLower Price TargetHold$4.00 ➝ $3.50High
i
8/8/2019Royal Bank of CanadaReiterated RatingHold$5.00Low
i
8/7/2019Piper Jaffray CompaniesSet Price TargetSell$3.00Medium
i
Rating by Sarah James at Piper Jaffray Companies
4/17/2019BarclaysSet Price TargetSell$3.00Medium
i
Rating by Steven Valiquette at Barclays PLC
2/22/2019Morgan StanleySet Price TargetSell$4.00High
i
Rating by Zachary Sopcak at Morgan Stanley
2/22/2019BarclaysSet Price TargetSell$4.00High
i
Rating by Steven Valiquette at Barclays PLC
11/15/2018UBS GroupInitiated CoverageSell ➝ Sell$2.00High
i
10/31/2018Cantor FitzgeraldLower Price TargetNeutral ➝ Neutral$6.00 ➝ $4.00Low
i
10/11/2018Cantor FitzgeraldReiterated RatingHold$6.00Medium
i
8/16/2018Morgan StanleyLower Price TargetUnderweight ➝ Underweight$3.50 ➝ $3.00Medium
i
8/14/2018BarclaysInitiated CoverageUnderweight$3.00High
i
7/27/2018Robert W. BairdReiterated RatingNeutral ➝ Hold$5.00 ➝ $4.00High
i
7/27/2018Piper Jaffray CompaniesReiterated RatingSell$3.00High
i
7/27/2018MizuhoSet Price TargetHold$4.00Low
i
Rating by Ann Hynes at Mizuho
7/27/2018Bank of AmericaLower Price TargetUnderperform ➝ Underperform$4.50 ➝ $4.00Medium
i
7/27/2018Jefferies Financial GroupReiterated RatingHold$4.00High
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
7/20/2018SunTrust BanksReiterated RatingHold$3.00Low
i
7/13/2018Morgan StanleyLower Price TargetUnderweight$4.00 ➝ $3.75High
i
5/1/2018Cantor FitzgeraldReiterated RatingHold$6.00High
i
3/23/2018MizuhoInitiated CoverageNeutralHigh
i
3/22/2018MizuhoReiterated RatingHold$4.50High
i
3/6/2018Jefferies Financial GroupSet Price TargetHold$5.00Medium
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
2/1/2018Cantor FitzgeraldReiterated RatingHold$6.00Low
i
1/30/2018Wells Fargo & CompanyInitiated CoverageUnderperform ➝ Underperform$4.50Low
i
1/11/2018Cantor FitzgeraldReiterated RatingHold$6.00High
i
1/3/2018The Goldman Sachs GroupInitiated CoverageSell ➝ Sell$3.00High
i
12/14/2017JPMorgan Chase & Co.DowngradeNeutral ➝ UnderweightHigh
i
11/7/2017Royal Bank of CanadaReiterated RatingHold$5.00N/A
i
11/5/2017Cantor FitzgeraldReiterated RatingHold$6.00N/A
i
11/3/2017MizuhoReiterated RatingHold$3.50N/A
i
11/3/2017CitigroupLower Price TargetNeutral$7.00 ➝ $5.00N/A
i
11/3/2017Morgan StanleyLower Price TargetUnderweight$6.50 ➝ $4.50N/A
i
11/2/2017Credit Suisse GroupInitiated CoverageUnderperform ➝ Underperform$3.50N/A
i
10/15/2017SunTrust BanksSet Price TargetHold$7.00N/A
i
Rating by David S Macdonald at SunTrust Banks, Inc.
10/13/2017Piper Jaffray CompaniesReiterated RatingSell$6.00N/A
i
10/12/2017MizuhoReiterated RatingHold$7.00N/A
i
10/12/2017Jefferies Financial GroupReiterated RatingHold$7.00N/A
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
10/4/2017Robert W. BairdReiterated RatingHold$7.00High
i
9/7/2017KeyCorpReiterated RatingHoldLow
i
9/5/2017Jefferies Financial GroupReiterated RatingHold$7.00Medium
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
9/1/2017Robert W. BairdReiterated RatingHold$7.00High
i
8/23/2017UBS GroupReiterated RatingNeutral$10.00 ➝ $8.00Low
i
8/16/2017Cantor FitzgeraldReiterated RatingNeutral$8.00 ➝ $7.00Low
i
8/4/2017Royal Bank of CanadaReiterated RatingHold$7.00Low
i
8/3/2017Deutsche Bank AktiengesellschaftLower Price TargetHold$13.00 ➝ $8.00Low
i
8/3/2017Piper Jaffray CompaniesReiterated RatingSell$6.00Low
i
8/2/2017MizuhoReiterated RatingNeutral$7.50 ➝ $7.00Low
i
Rating by Sheryl Skolnick at Mizuho
7/30/2017Jefferies Financial GroupReiterated RatingHold$7.00High
i
7/26/2017Piper Jaffray CompaniesReiterated RatingSell$9.00Medium
i
6/6/2017Morgan StanleyInitiated CoverageUnderweight ➝ Underweight$9.50Low
i
4/5/2017Deutsche Bank AktiengesellschaftInitiated CoverageHold$11.00High
i
3/27/2017MizuhoLower Price TargetNeutral$10.00 ➝ $7.50Low
i
Rating by Sheryl Skolnick at Mizuho
3/13/2017MizuhoReiterated RatingHoldLow
i
Rating by Sheryl Skolnick at Mizuho
3/1/2017Piper Jaffray CompaniesDowngradeNeutral ➝ Underweight$10.00 ➝ $7.00N/A
i
2/22/2017Robert W. BairdUpgradeUnderperform ➝ Neutral$5.00 ➝ $9.00N/A
i
2/22/2017Cantor FitzgeraldBoost Price TargetNeutral$7.00 ➝ $8.00N/A
i
2/21/2017Jefferies Financial GroupReiterated RatingHold$8.00N/A
i
2/21/2017MizuhoUpgradeUnderperform ➝ Neutral$3.00 ➝ $7.50N/A
i
Rating by Sheryl Skolnick at Mizuho
1/9/2017BarclaysReiterated RatingHold$7.00N/A
i
1/4/2017Piper Jaffray CompaniesInitiated CoverageNeutral$6.00N/A
i
11/14/2016Cantor FitzgeraldReiterated RatingHold$7.00N/A
i
11/11/2016Credit Suisse GroupDowngradeNeutral ➝ Underperform$7.00 ➝ $4.25N/A
i
11/9/2016Royal Bank of CanadaReiterated RatingSector Perform$15.00 ➝ $6.00N/A
i
11/9/2016Royal Bank of CanadaBoost Price TargetSector Perform$6.00 ➝ $15.00N/A
i
11/6/2016Susquehanna BancsharesReiterated RatingPositive$18.00 ➝ $10.00N/A
i
10/28/2016Jefferies Financial GroupReiterated RatingHold$11.75 ➝ $9.00N/A
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
10/28/2016Credit Suisse GroupReiterated RatingNeutral$7.00N/A
i
10/28/2016Cantor FitzgeraldReiterated RatingHold$12.00N/A
i
Rating by Joseph France at Cantor Fitzgerald
10/27/2016Bank of AmericaReiterated RatingUnderperform$10.00 ➝ $6.00N/A
i
Rating by Kevin Fischbeck at Bank of America Co.
10/27/2016Robert W. BairdDowngradeNeutral ➝ Underperform$12.00 ➝ $8.00N/A
i
Rating by Whit Mayo at Robert W. Baird
10/27/2016MizuhoDowngradeNeutral ➝ UnderperformN/A
i
Rating by Sheryl Skolnick at Mizuho
10/26/2016Avondale PartnersReiterated RatingMarket PerformN/A
i
Rating by P. Torch at Avondale Partners
10/25/2016Wolfe ResearchInitiated CoverageMarket PerformN/A
i
10/4/2016SVB LeerinkReiterated RatingHoldN/A
i
Rating by Ana Gupte at SVB Leerink LLC
10/4/2016MizuhoReiterated RatingNeutral$10.50N/A
i
10/1/2016CitigroupSet Price TargetHold$12.00N/A
i
Rating by Ralph Giacobbe at Citigroup Inc.
9/20/2016SVB LeerinkReiterated RatingHoldN/A
i
Rating by ana gupte at SVB Leerink LLC
9/19/2016Robert W. BairdReiterated RatingNeutral$12.00N/A
i
Rating by Whit Mayo at Robert W. Baird
9/19/2016CitigroupSet Price TargetHold$14.00N/A
i
Rating by ralph giacobbe at Citigroup Inc.
9/14/2016Susquehanna BancsharesUpgradeNeutral ➝ Positive$10.78 ➝ $18.00N/A
i
8/22/2016UBS GroupReiterated RatingHoldN/A
i
Rating by A.J. Rice at UBS Group AG
8/19/2016BarclaysReiterated RatingHold$15.00N/A
i
8/12/2016MizuhoUpgradeUnderperform ➝ Neutral$10.50N/A
i
8/10/2016Jefferies Financial GroupReiterated RatingHoldN/A
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
8/9/2016SVB LeerinkDowngradeOutperform ➝ Market Perform$21.00 ➝ $13.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
8/5/2016CitigroupLower Price TargetNeutral$17.00 ➝ $14.00N/A
i
8/4/2016BarclaysLower Price TargetEqual Weight$17.00 ➝ $15.00N/A
i
8/3/2016Morgan StanleyReiterated RatingSell$15.00N/A
i
Rating by Andrew Schenker at Morgan Stanley
8/3/2016UBS GroupDowngradeBuy ➝ NeutralN/A
i
7/29/2016Credit Suisse GroupInitiated CoverageNeutral$14.00 ➝ $14.00N/A
i
6/13/2016LADENBURG THALM/SH SHUpgradeNot Rated ➝ UnderperformN/A
i
6/1/2016Raymond JamesDowngradeMarket Perform ➝ UnderperformN/A
i
Rating by John Ransom at Raymond James
6/1/2016BarclaysLower Price TargetEqual Weight$32.00 ➝ $29.00N/A
i
5/24/2016Morgan StanleyDowngradeEqual Weight ➝ Underweight$15.00N/A
i
Rating by Andrew Schenker at Morgan Stanley
5/16/2016Robert W. BairdReiterated RatingHoldN/A
i
Rating by Whit Mayo at Robert W. Baird
(Data available from 5/8/2016 forward)
Community Health Systems logo
Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, retail clinics, and via direct-to-consumer virtual health visits. As of December 31, 2020, it owned or leased 89 hospitals, including 87 general acute care hospitals and two stand-alone rehabilitation or psychiatric hospitals with an aggregate of 14,110 licensed beds. The company was founded in 1985 and is headquartered in Franklin, Tennessee.
Read More

Today's Range

Now: $15.22
$13.84
$15.30

50 Day Range

MA: $11.71
$9.67
$14.01

52 Week Range

Now: $15.22
$2.46
$15.30

Volume

3,984,945 shs

Average Volume

2,771,973 shs

Market Capitalization

$2.01 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.12

Frequently Asked Questions

What sell-side analysts currently cover shares of Community Health Systems?

The following Wall Street sell-side analysts have issued research reports on Community Health Systems in the last year: Citigroup Inc., Credit Suisse Group AG, Jefferies Financial Group Inc., Raymond James, TheStreet, Truist, and Zacks Investment Research.
View the latest analyst ratings for CYH.

What is the current price target for Community Health Systems?

4 Wall Street analysts have set twelve-month price targets for Community Health Systems in the last year. Their average twelve-month price target is $10.88, suggesting a possible downside of 28.5%. Jefferies Financial Group Inc. has the highest price target set, predicting CYH will reach $18.00 in the next twelve months. Citigroup Inc. has the lowest price target set, forecasting a price of $3.50 for Community Health Systems in the next year.
View the latest price targets for CYH.

What is the current consensus analyst rating for Community Health Systems?

Community Health Systems currently has 3 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CYH, but not buy more shares or sell existing shares.
View the latest ratings for CYH.

What other companies compete with Community Health Systems?

How do I contact Community Health Systems' investor relations team?

Community Health Systems' physical mailing address is 4000 MERIDIAN BOULEVARD, FRANKLIN TN, 37067. The company's listed phone number is 615-465-7000 and its investor relations email address is [email protected] The official website for Community Health Systems is www.chs.net.

The Name of the #1 Stock to Trade in 2021
Expert Jeff Clark is releasing his #1 stock to trade in 2021.

Since he started recommending this stock, you could have used it for gains as high as 269% and even 273%... in as little as 8 days.